Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation (IART) — Form 8-K: Current report
About this filing
Integra LifeSciences Holdings Corporation (IART) filed an 8-K on Oct 19, 2026 reporting entry into a material agreement (Item 1.01), termination of a material agreement (Item 1.02), new debt or another financial obligation (Item 2.03) and 1 more item, with exhibits (Item 9.01).
Key facts
- Item 1.01 · Entry into a material agreement
- Item 1.02 · Termination of a material agreement
- Item 2.03 · New debt or another financial obligation
- Item 7.01 · Regulation FD disclosure
- Item 9.01 · Financial statements and exhibits
More IART filings
- SC 13G
Filed Nov 10, 2026
- 10-Q
Filed Oct 23, 2026
- 8-K
Filed Oct 21, 2026
- 3
Filed Oct 13, 2026
- 8-K
Filed Oct 9, 2026
- 8-K
Filed Oct 2, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.